Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Tartour

Showing results (11-20 of 227) with videos related to

Pageof 23
Sort By:
European Journal of Immunology|January 17, 2013
NK cells from pleural effusions are potent antitumor effector cellsMagali Terme, Wolf Hervé Fridman, Eric Tartour
Trends in Pharmacological Sciences|March 12, 2014
Targeting CCR4 as an emerging strategy for cancer therapy and vaccinesJagadeesh Bayry, Eric Tartour, David F Tough
Bulletin Du Cancer|January 7, 2017
Franck Pagès, Jacques-Olivier Bay, Eric Tartour
Molecular Medicine (Cambridge, Mass.)|February 14, 2024
Hypothesis of a CD137/Eomes activating axis for effector T cells in HPV oropharyngeal cancersRobin Baudouin, Eric Tartour, Cécile Badoual, et al.
Oncoimmunology|September 28, 2013
Following up tumor-specific regulatory T cells in cancer patientsLaurence Zitvogel, Corinne Tanchot, Clemence Granier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Hope in the Long Road Toward the Development of a Therapeutic Human Papillomavirus VaccineSoumaya Karaki, Helene Pere, Cecile Badoual, et al.
Frontiers in Oncology|April 16, 2014
Control of the adaptive immune response by tumor vasculatureLaetitia Mauge, Magali Terme, Eric Tartour, et al.
Bulletin Du Cancer|January 7, 2017
Franck Pagès, Clémence Granier, Amos Kirilovsky, et al.
Journal of Immunological Methods|October 21, 2018
Analytical validation of an alternative method to quantify specific antibodies in 3 applicationsMarie Senant, Pauline Bordereau, Eric Tartour, et al.
Medecine Sciences : M/S|October 27, 2011
[Cancer immunotherapy: recent breakthroughs and perspectives]Eric Tartour, Federico Sandoval, Jean-Yves Bonnefoy, et al.
Pageof 23

Showing results (11-20 of 227) with videos related to

Sort By:
Pageof 23
European Journal of Immunology|January 17, 2013
NK cells from pleural effusions are potent antitumor effector cellsMagali Terme, Wolf Hervé Fridman, Eric Tartour
Trends in Pharmacological Sciences|March 12, 2014
Targeting CCR4 as an emerging strategy for cancer therapy and vaccinesJagadeesh Bayry, Eric Tartour, David F Tough
Bulletin Du Cancer|January 7, 2017
Franck Pagès, Jacques-Olivier Bay, Eric Tartour
Molecular Medicine (Cambridge, Mass.)|February 14, 2024
Hypothesis of a CD137/Eomes activating axis for effector T cells in HPV oropharyngeal cancersRobin Baudouin, Eric Tartour, Cécile Badoual, et al.
Oncoimmunology|September 28, 2013
Following up tumor-specific regulatory T cells in cancer patientsLaurence Zitvogel, Corinne Tanchot, Clemence Granier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Hope in the Long Road Toward the Development of a Therapeutic Human Papillomavirus VaccineSoumaya Karaki, Helene Pere, Cecile Badoual, et al.
Frontiers in Oncology|April 16, 2014
Control of the adaptive immune response by tumor vasculatureLaetitia Mauge, Magali Terme, Eric Tartour, et al.
Bulletin Du Cancer|January 7, 2017
Franck Pagès, Clémence Granier, Amos Kirilovsky, et al.
Journal of Immunological Methods|October 21, 2018
Analytical validation of an alternative method to quantify specific antibodies in 3 applicationsMarie Senant, Pauline Bordereau, Eric Tartour, et al.
Medecine Sciences : M/S|October 27, 2011
[Cancer immunotherapy: recent breakthroughs and perspectives]Eric Tartour, Federico Sandoval, Jean-Yves Bonnefoy, et al.
Pageof 23